The inner link between HDAC and the classical resistant mechanisms might be illustrated by the previous literatures: (1) Dowdy et al.33 reported that TSA, an HDAC inhibitor, stabilized microtubules via α-tubulin acetylation in endometrial cancer cells and enhanced paclitaxel effects. This evidence concerns the gene HDAC9 and endometrial cancer.